Skip to navigation Skip to content

Clinical Trial: Virtual versus usual in-office care for MS

Share

Details
Type of MS: PPMS|PRMS|RRMS|SPMS
Number of Subjects: 120
Medication: Virtual versus usual in-office care
Location: California|Ohio
Contact Information
Please see below for contact information.

Funding:

The National Institute of Nursing Research (NINR).

Description

SUMMARY
The VIRTUAL-MS (Virtual versus usual in-office care for multiple sclerosis) study taking place at the Cleveland Clinic and the University of California San Francisco is comparing healthcare delivery via Telehealth and In-Person clinic visits. 120 people diagnosed with MS will be recruited across both sites and will randomly be assigned to receive their healthcare via Telehealth or in-person at each site’s campus location.
 
DETAILS
Rationale: There are many barriers individuals with MS face in accessing healthcare including financial limitations, physical limitations when attending appointments, travel time, and the decreasing number of neurologists in healthcare. Access to Telehealth may help reduce some of this cost and the burden on people by potentially reducing lodging and travel costs, time spent travelling to appointments, reducing missed days of work, and reduced burden on caregivers. This study will look at these factors to help individuals determine the most cost effective and practical MS healthcare option that helps people with MS have the best outcomes.
 
Eligibility and Details: Investigators are seeking participants diagnosed with Multiple Sclerosis who are at least 18 years of age or older. Participants are eligible if they have been diagnosed with MS over the last 12 months.
 
Eligible participants will be randomly assigned into one of two groups. They will have an equal chance of being chosen for either group. Group 1 will attend 5 in-person MS healthcare visits over the course of 24 months at their site’s designated location. Group 2 will attend 2 in-person clinic visits and 3 healthcare visits via Telehealth with their neurologist.
 
During the 2 years that they are enrolled in the study, participants will have regular check-ups with their MS healthcare team. If their neurologist deems it necessary at any point during the study, participants may be switched to attend in-person clinic visits.
 
The primary outcome being measured by Multiple Sclerosis Functional Composite (MSFC), which measures walking speed, hand function, processing speed, and low contrast visual acuity scores at Month 24. Investigators will also monitor disability progression as measured by the EDSS scale, relapses, MRI activity, quality of life, other patient questionnaires, and safety.
 
Contact: To learn more about the enrollment criteria for this study, and to find out if you are eligible to participate at the Cleveland Clinic Mellen Center please contact Megan Roser at (216)444-5441. For participation at the University of San Francisco please contact Jaeleene Wijangco at 415-353-2174.
 
Sites will be enrolling in the following cities in the United States:
Cleveland, OH
San Francisco, CA

Share


© 2024 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.